Published

Rediscovering Psilocybin as an Antidepressive Treatment Strategy.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Pharmaceuticals (Basel, Switzerland)
Date: 2021-09-28
Source: PubMed
DOI: 10.3390/ph14100985
PubMed: 34681209

Authors

Zeiss R Gahr M Graf H

Watch author

Derived topics and classifications

psilocybin psilocin Depression Pharmacology Mechanism of Action Review Article Safety Adverse Events Review Article

Citation graph

0 referenced DOIs found in stored source metadata. 4 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Psilocybin in Neuropsychiatric Disorders: Seeking Valuable Evidence in History, Pure Science, Clinical Trials and Real-World Data (RWD)2026-03-26 Synthesis of Psilocin, Psilocybin and 5-MeO-DMT Succinate, All Labelled With Carbon-14 at the Indole 2-Position2025-07-01 The molecular structure, vibrational spectra, solvation effect, non-covalent interactions investigations of psilocin2024-11-01 Rediscovering Psilocybin as an Antidepressive Treatment Strategy.2021-09-28

Related papers

Editorial: Psychedelic-assisted psychotherapies: from clinical trials to credibility.Frontiers in neuroscience · 2026-01-01 Psychedelics and mental health: reimagining care through science, insight, and compassion.Frontiers in pharmacology · 2025-01-01 Narrative therapy-assisted psilocybin use for treatment of depressionSeattle Pacific University Research Conference · 2017-01-01 Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related Psychological DistressWestern CEDAR (Western Washington University) · 2018-01-01